Preparation of Mn
2+ chelated P(CitAPDMAEMA)@Au@TiO2@DOX. The P(CitAPDMAEMA)@Au@TiO2@DOX NPs (1.0 mg/mL) were labeled with Mn 2+ by adding of MnCl2 solution (1.0 mg/mL) at the neutral condition. After 4 h stirring at 37 o C, the samples were centrifuged for several times to remove unbound excess Mn
2+
.
The concentration of Mn 2+ in the obtained nano-complexes was determined to be 78 mg/g by inductively coupled plasma-mass spectrometry (ICP-MS) analysis.
Photothermal performance of P(CitAPDMAEMA)@Au@TiO2@DOX NPs.
Measurement of photothermal performance: aqueous-dispersion P(CitAPDMAEMA)@Au@TiO2@DOX NPs (1.0 mL) with different concentrations (0-200 μg/mL) were introduced in a quartz cuvette and irradiated with 635 nm laser at a power density of 2.0 W/cm 2 for 5 min to measure the photothermal conversion performance of P(CitAPDMAEMA)@Au@TiO2@DOX NPs.
P(CitAPDMAEMA)@Au@TiO2@DOX NPs (200 μg/mL) were then irradiated by laser power densities (2.0 W/cm 2 ) to investigate the laser power dose effect.
Temperature was recorded every 1 s by a digital thermometer using a thermocouple probe with an accuracy of 0.1°C. Real-time thermal imaging of the samples was recorded using a thermal infrared camera and was quantified by examiner software.
Photothermal conversion efficiency was evaluated by recording the temperature change of the aqueous dispersion (200 μg/mL) as a function of time under 635 nm laser irradiation at a power density of 2.0 W/cm 2 until the solution reached a steady-state temperature. Photothermal conversion efficiency, η, was calculated using Equation (1), as described by referring to the previous literatures.
where h is the heat transfer coefficient, A is the surface area of the container, Tmax is the equilibrium temperature, Tsurr is the ambient temperature of the surroundings, QDis expresses the heat dissipation from the light absorbed by the quartz sample cell, I is incident laser power (2.0 W/cm 2 ), and A635 is the absorbance of P(CitAPDMAEMA)@Au@TiO2@DOX NPs at 635 nm (0.09). The value of hA is derived according to Equation (2): τS= mDCD/hA (2) where τs is the sample system time constant, mD and CD are the mass (1.0 g) and heat capacity (4.2 J/g) of deionized water used as a solvent, respectively. QDis (210 mW) was independently measured using a quartz cuvette cell containing pure water without P(CitAPDMAEMA)@Au@TiO2@DOX NPs.
In order to get the τ, we herein introduce a parameter θ, which is defined as the ratio of ΔT to ΔTmax
ΔT is the temperature change, which is defined as T-Tsurr (T and Tsurr are the solution temperature and ambient temperature, respectively), and ΔTmax is the temperature change at the maximum steady-state temperature t = -τ ln(θ) (4)
Thus, τ can be determined by applying the linear time data from the cooling period versus ln(θ). Therefore, hA can be calculated.
Photodegradation of DPBF.
Typically, 100 mL of ethanol solution with DPBF and P(CitAPDMAEMA)@Au@TiO2@DOX NPs were stirred in the dark for 100 min to reach the adsorption/desorption equilibrium prior to the test. The mixture was irradiated by laser of 635 nm for 5 min. The samples were taken at different times for UV-vis measurements. For comparison, the ROS production of acetonitrile solution without P(CitAPDMAEMA)@Au@TiO2@DOX NPs was also measured in parallel under the same condition.
Hydrolysis of citraconic amide of P(CitAPDMAEMA)@Au@TiO2@DOX. Hemolysis assay of P(CitAPDMAEMA)@Au@TiO2@DOX NPs. Fresh rabbit whole blood was offered from Jiangsu Blood Center. Briefly, fresh rabbit whole blood was diluted in PBS to achieve 8% blood content. P(CitAPDMAEMA), P(CitAPDMAEMA)@Au@TiO2@DOX NPs (WDOX : WAu@TiO2 = 3), and DOX solutions (100 μL) of different concentration were mixed with equal volume of the diluted blood suspension. The mixtures were incubated at 37°C for 2 h, and then subjected to centrifugation at 1500 rpm for 10 min. After which the supernatant (100 μL) was transferred into a 96-well plate. The hemoglobin release was evaluated by measuring the optical absorbance at 576 nm using a microplate reader. Triton-100, 40 mM Tris acetate, 10 mM EDTA, and 10 mM DTT). To extract DOX from blood, 300 μL of HCl/isopropanol was added. Then, the mixture was incubated in dark overnight. By centrifuging to obtain the DOX in supernatant, the amount of DOX remaining in blood was determined by fluorescence.
In vivo combination therapy. HeLa tumor-bearing mice were divided into five groups, P(CitAPDMAEMA)@Au@TiO2@DOX NPs (1) (P(BocAPDMAEMA)), was synthesized by BocAPDMAEMA using 4-cyanopentanoic acid dithiobenzoate as chain transfer agent [2] . Then, P(BocAPDMAEMA) was confirmed 1 H and C 13 NMR spectroscopy ( Figure S5A -B).
Finally, P(APDMAEMA) was modified using citraconic anhydride to obtain the poly(N'-citraconyl-2-(3-aminopropyl-N,N-dimethylammonium)ethyl methacrylate)
[P(CitAPDMAEMA)], with 100% of the primary amine groups in P(APDMAEMA) converted into amides, which was confirmed by 
